Ribociclib-induced pulmonary infiltrates in a patient with breast cancer.

Oktay ÜnsalAhmet Özet

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

The pulmonary infiltrates that developed in the patient increased with continued use of ribociclib, suggesting that this was due to ribociclib. The Naranjo Adverse Drug Reaction Probability Scale also indicates probable relationship.

Keyphrases

adverse drug
pulmonary hypertension
case report
drug induced
high glucose
emergency department
diabetic rats
electronic health record
oxidative stress
young adults
endothelial cells